Transient loss of detectable HIV-1 RNA following brentuximab vedotin anti-CD30 therapy for Hodgkin lymphoma.

ABSTRACT:

SUBMITTER: Wang CC 

PROVIDER: S-EPMC6290106 | biostudies-literature | 2018 Dec

REPOSITORIES: biostudies-literature